INTRODUCTION
============

Targeted mRNA delivery to specific subcellular compartments and localized protein synthesis are crucial for various cellular and physiological functions. One major and well-studied mRNA targeting pathway is the translation-dependent delivery of secreted/membrane proteins (mSMPs) into the endoplasmic reticulum (ER), as initially described by [@B7]). According to this model, ribosomes engaged in mSMP translation are recognized by the signal recognition particle (SRP) via the signal peptide present at the amino terminus of the newly synthesized polypeptide. The SRP binds the ribosome--mRNA--nascent polypeptide chain complex via the signal peptide and traffics it from the cytoplasm to the ER. mRNA anchoring is then achieved through binding of the SRP to its receptor on the ER membrane, and protein elongation across the membrane is carried out via a protein-conducting channel called the translocon ([@B47]). According to this model, the *cis-*acting element directing mRNA localization is not a sequence contained within the mRNA but instead the amino acid sequence of the newly translated signal peptide, which serves as a positive selection signal to recruit the SRP. Although the SRP model has been widely accepted, it is unclear whether all mRNAs target the ER in a translation-dependent manner or whether other pathways for RNA delivery exist. Based mainly on studies using prokaryotes ([@B6]), an alternative model suggests that mRNA and ribosomes can undergo independent targeting to membranes by which ribosomes access membranes via an association with the SRP receptor, whereas mRNAs are targeted independently of translation by *cis*-acting sequences contained within the transcript.

Evidence for SRP-independent mRNA localization to the ER has emerged (reviewed in [@B27]). Several groups have examined the distribution of mRNAs coding for cytosolic and membrane-bound proteins between the cytosol and ER-bound polyribosome fractions ([@B15]; [@B30]; [@B43]) and found that a large number of mRNA species (\>9000 in mammalian cells) are shared between the two compartments. More recently, Nicchitta and colleagues examined the partitioning of mRNAs encoding three classes of proteins ---cytosolic, endomembrane, and secretory cargo---between the ER and cytosol. All three classes were found spread between the two compartments, with mRNAs encoding secretory cargo showing a broad spectrum of distribution and mRNAs encoding proteins that lack a signal sequence fractionating with the ER ([@B11]). Thus lack of a signal sequence does not prevent the localization of mRNAs encoding cytosolic proteins to ER membranes ([@B37]; [@B43]; [@B11]). This pattern of localization was not altered in cells either lacking a component of the SRP complex or treated with protein synthesis inhibitors ([@B30]; [@B43]), whereas the disruption of polysome aggregation (using EDTA) or removal of the signal sequence also did not alter the distribution of mRNAs from the ER ([@B43]). Similarly, certain mRNAs in *Escherichia coli* were also found to translocate to the inner membrane independently of translation ([@B36]). Thus these different studies provide substantial evidence that alternative paths may direct mRNAs to the ER even when the SRP pathway and translation are interrupted. Of importance, this finding may explain why loss of the SRP pathway in yeast and in higher eukaryotes does not result in lethality ([@B35]; [@B29]).

According to the classic SRP model, an mRNA must be translated in order for the signal peptide to serve as an ER-targeting device. Sequence analysis of mSMPs from different organisms, however, reveals the existence of unique features ([@B41]; [@B42]) that suggest that mRNAs might contain SRP-independent targeting information. For example, a recent nonbiased analysis of mRNA nucleotide composition ([@B42]) showed that mRNAs encoding membrane proteins are strongly biased toward containing uracil (U-biased; [@B42]) due to the use of uracil in codons for hydrophobic amino acids. Of probable relevance, a uracil-rich sequence contained within the extensive 3′ untranslated region (UTR; which likely results from a premature transcription termination site) of the yeast *PMP1* gene is sufficient to mediate mRNA targeting in a translation-independent manner ([@B33]). Moreover, genomic analyses demonstrate that nucleotide stretches encoding signal sequence--coding regions (SSCRs) in eukaryotes have decreased use of adenines (A) and create "no-A" stretches in these tracts ([@B41]). Together the data suggest that mSMPs include sequence information that distinguishes them from the general mRNA population. Finally, although ER-targeting motifs for mRNAs are not well defined, several RNA-binding proteins (RBPs) in yeast (e.g., She2, Scp160, Puf1, Puf2, and Whi3) preferentially bind mRNAs associated with the secretory pathway and may serve in SRP-independent mRNA-delivery pathways ([@B31]; [@B19]; [@B25]; [@B45]; [@B2]; [@B12]; [@B18]).

In this study, we describe the localization of endogenously expressed mSMPs that encode ER-resident proteins and proteins that either localize later in the secretory pathway or are secreted from the cell. By using three different and complementary procedures---in vivo fluorescence microscopy, in situ hybridization, and subcellular fractionation and reverse transcription (RT)-PCR---we show that mSMPs reside on ER membranes and, in particular, on ER that is peripheral to the nucleus (nER). mRNA association with the ER was not abolished by the inhibition of translation or inactivation of SRP, the latter accomplished using a temperature-sensitive allele of *SRP65*, and even synthetic nontranslatable uracil-rich mRNAs were found to be ER localized. In contrast, non-mSMPs (e.g., *FSH3*) were either distributed equally between the ER and cytosol or enriched in the cytosolic fraction. Together the results indicate that multiple mRNAs are targeted to the ER in a manner that is independent of translation and SRP but may involve *cis-*acting sequence elements and *trans*-acting RBPs.

RESULTS
=======

Endogenously expressed mSMPs colocalize with ER, as shown by fluorescence microscopy
------------------------------------------------------------------------------------

To visualize endogenously expressed mSMPs in living yeast, we used m-TAG, a chromosomal tagging procedure that inserts 12 MS2 aptamer loop (MS2L) sequences between the open reading frame (ORF) and 3′UTR for any gene of interest via homologous recombination ([@B23]; [@B21]). Subsequently the MS2 aptamer-tagged mRNA can be visualized upon the induced expression of the bacteriophage MS2 coat protein (MS2-CP) fused to several copies of green fluorescent protein (GFP; e.g., MS2-CP-GFP(x3) or (x4)). This technique has been used to successfully localize in vivo endogenously expressed mRNAs to the ER, mitochondria, peroxisome, and actin patches ([@B23]; [@B51]; [@B17]; [@B10]).

We determined mSMP localization by examining colocalization of the GFP-labeled mRNA granules with red fluorescent protein (RFP)--tagged Sec63, an ER marker. ER localization was divided into four categories: nuclear ER (nER), cortical ER (cER), both nuclear and cortical ER (both), and non-ER localization (Supplemental Figure S1). We tagged 11 genes coding mSMPs (*ALG1*, *GOS1*, *ICE2*, *NYV1*, *PEP12*, *PMT1*, *SEC22*, *SUC2*, *SUR4*, *USE1*, and *YIP3*) and two non-SMP controls that encode non--membrane-anchored, soluble *N*-ethylmaleimide--sensitive factor attachment protein receptors (SNAREs; *SEC9*, *SEC20*) of the secretory pathway that localize to the plasma membrane and ER, respectively. Representative images of the different tagged strains are shown in [Figure 1](#F1){ref-type="fig"}, and statistics for the scoring of mRNA localization to the ER (∼100 cells scored for each experiment; *n* = 2 or 3 experiments) are given in [Table 1](#T1){ref-type="table"}. In the cases in which fluorescent granules were hard to detect using MS2-CP-GFP(x3), probably due to low levels of gene expression, we used MS2-CP-GFP(x4) (i.e., fused to four GFP molecules; [@B51]). Because we found that MS2-CP-GFP(x4) can induce the accumulation of fluorescent aggregates in a low percentage (8%) of wild-type cells ([@B51]; and data not shown), we took care not to count cells containing large aggregates and minimized MS2-CP-GFP(x4) induction by growing cells in medium containing methionine (i.e., without direct induction), which results in residual gene expression from the somewhat leaky *MET25* promoter. Under these conditions typically only one RNA granule per cell was observed. In addition, we found no significant difference in the localization of mSMPs using MS2-CP-GFP(x3) or MS2-CP-GFP (x4). For example, fluorescent aptamer-tagged *USE1* granules showed 86% colocalization with ER using MS2-CP-GFP(x3) for detection and 83% colocalization using MS2-CP-GFP(x4) ([Table 1](#T1){ref-type="table"}).

![Visualization of endogenous mSMPs and their colocalization with ER. Cells bearing the *MS2L* aptamer sequence integrated into genes encoding various mSMPs and secretory pathway components were transformed with plasmids expressing MS2-CP-GFP(x3) or MS2-CP-GFP(x4) (see [Table 1](#T1){ref-type="table"} for details) and Sec63-RFP (an ER marker). Cells expressing MS2-CP-GFP(x3) were grown on liquid synthetic medium and induced with the same medium lacking methionine for 1 h before visualization. Cells expressing MS2-CP-GFP(x4) were grown on liquid synthetic medium without induction. For *SUC2* mRNAs, cells were grown on low glucose (0.1%)--containing medium to induce SUC2 expression. Percentage of fluorescent RNA granules colocalized with ER (% Local.). mRNA, localization of GFP-labeled RNA granules; ER, localization of ER labeled with Sec63-RFP; mRNA/ER, merger of ER and mRNA windows; Merge (All), merger of light (differential interference contrast), ER, and mRNA windows. Scale bar, 1 μm.](3069fig1){#F1}

###### 

Localization to the ER of endogenous mRNAs encoding secretory pathway proteins.

                                                    Percentage of RNA granules colocalized with ER                        
  --------- ------------------------ ---- ---- ---- ------------------------------------------------ ------ ------ ------ ------------
  YGL098W   *USE1* (WT)              \+   \+        26.0                                             52.1   8.2    13.7   86.2
  YGL098W   *USE1* (WT)              \+        \+   23.5                                             55.6   4.3    16.6   83.4
  YIL162W   *SUC2* (WT)              \+        \+   31.2                                             42.5   7.5    18.8   81.2
  YLR372W   *SUR4* (WT)              \+        \+   20.7                                             52.8   5.6    20.9   79.1
  YNL044W   *YIP3* (WT)              \+        \+   29.1                                             39.5   10.2   20.9   78.8
  YAL023C   *PMT2* (WT)              \+        \+   28.8                                             44.2   3.8    23.2   76.8
  YIL090W   *ICE2* (WT)              \+        \+   34.0                                             35.0   7.0    24.0   76.0
  YOR036W   *PEP12* (WT)             \+        \+   46.0                                             22.1   6.0    25.9   74.0
  YBR110W   *ALG1* (WT)              \+        \+   33.7                                             31.0   7.6    26.9   72.3
  YHL031C   *GOS1* (WT)              \+        \+   44.0                                             17.7   8.8    29.5   70.5
  YGR009C   *SEC9* (WT)              \+        \+   34.2                                             21.4   5.7    38.7   61.3
  YLR093C   *NYV1* (WT)              \+        \+   34.3                                             18.8   3.1    43.8   56.2
  YDR498C   *SEC20* (WT)             \+             16.6                                             35.0   5.0    43.4   56.6
  YLR268W   *SEC22* (WT)             \+        \+   32.8                                             20     3.10   44.1   55.9
            *USE1* (*she2Δ*)         \+   \+        34.2                                             40.3   5.6    19.9   80.1 ± 7.3
            *USE1* (*whi3Δ*)         \+   \+        36.1                                             44.6   3.1    16.2   83.8 ± 2.6
            *USE1* (*puf1Δ*)         \+   \+        34.7                                             40.9   7.6    16.8   83.2 ± 5.1
            *USE1* (*puf2Δ*)         \+   \+        23.2                                             42.2   4.8    29.8   70.2 ± 6.6
            *SUC2* (*she2Δ*)         \+        \+   32.6                                             28.8   1.0    37.6   62.4 ± 6.4
            *SUC2* (*whi3Δ*)         \+        \+   38.7                                             35.5   6.5    19.3   80.7 ± 0.0
            *SUC2* (*puf1Δ*)         \+        \+   31.8                                             39.9   3.9    24.4   75.6 ± 2.9
            *SUC2* (*puf2Δ*)         \+        \+   31.7                                             27.7   0.9    39.7   60.3 ± 1.8
            *SUC2* (*puf2Δ she2Δ*)   \+        \+   21.5                                             30.8   1.4    46.3   53.7 ± 1.9
                                                                                                                          
            *USE1* 10'CHX            \+   \+        33.7                                             46.2   5      15.1   84.9
            *USE1* 30'CHX            \+   \+        22.5                                             61.9   1.4    14.2   85.8
            *SUC2* 10'CHX            \+        \+   34.6                                             36.6   5.9    22.8   77.1
            *SUC2* 30'CHX            \+        \+   47.4                                             26.2   2.0    24.4   75.6

We examined mRNA localization by confocal microscopy and found that 9 of 11 mSMPs tagged (*ALG1*, *GOS1*, *ICE2*, *PEP12*, *PMT2*, *SUC2*, *SUR4*, *USE1*, and *YIP3*) showed high levels of granule colocalization with ER (\>70%; [Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), and 2 (*NYV1* and *SEC22*) showed lower levels of ER localization (56%; [Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). A similar low level of ER localization was observed with two mRNAs that encode soluble SNAREs (*SEC9* and *SEC20*) known to associate with the plasma and ER membranes ([Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Of interest, some preference toward nER localization was observed with mSMPs such as *PMT2*, *SUC2*, *SUR4*, *USE1*, and *YIP3*, whereas in contrast, most of the mRNAs encoding SNAREs (e.g., *GOS1*, *NYV1*, *PEP12*, *SEC9*, and *SEC22*) demonstrated a preference for cER ([Table 1](#T1){ref-type="table"}). It is important to note that unlike mRNAs encoding polarity and secretion factors (mPOLs; e.g., *SRO7*, *SEC3*, *SEC4*, *CDC42*, etc.), which localize with cER at the incipient bud site or bud tip ([@B2]), mSMP localization was restricted to the mother in small-budded cells (i.e., early in the cell cycle). Thus mSMPs are not polarized, unlike *ASH1* mRNA ([@B49]; [@B32]), mPOLs ([@B2]), and other mRNAs that use the She2 RBP for localization ([@B48]).

The highest levels of mSMP granule colocalization with ER were observed with *USE1* (86% colocalization), which encodes an essential tail-anchored SNARE involved in Golgi--ER retrograde transport ([@B4]; [@B16]), and *SUC2* (81% colocalization), which encodes the secreted enzyme invertase ([@B9]). Both mRNAs exhibit ER localization throughout the cell cycle (Supplemental Movies S1 and S2, respectively). *SUC2* mRNA localization was performed in cells shifted to 0.1% glucose for 1.5 h to induce expression of the mRNA encoding the secreted form of invertase instead of the constitutively expressed short form of *SUC2*, which lacks the signal sequence ([@B8]; [@B40]).

Endogenously expressed mSMPs colocalize with ER, as shown by subcellular fractionation
--------------------------------------------------------------------------------------

To verify that mSMPs physically associate with ER and that the MS2 aptamer sequence is not solely responsible for ER targeting, we lysed wild-type cells pretreated for 15 min with cycloheximide (to prevent the dissociation of translating RNAs) under conditions that preserve RNA and separated the postnuclear supernatant into cytosolic and microsomal fractions using nonlinear density gradient centrifugation. Separation of the cytosolic and ER-enriched microsome fractions was verified using antibodies to phosphoglycerate kinase (Pgk1) and dolichol phosphate mannose synthase (Dpm1), respectively ([Figure 2A](#F2){ref-type="fig"}). We also verified that the ER microsome fraction was not enriched with mitochondrial membranes, using an antibody to Tom70, a mitochondrial membrane protein, and that the level of mitochondrial contamination was minor (Supplemental Figure S2). After RNA extraction from the different fractions, both mSMPs and control mRNAs were detected in the fractions by semiquantitative RT-PCR (performed in duplicate). To avoid false positives that can arise from overamplification, we increased the number of cycles of amplification gradually for each gene examined. We found that mSMPs (e.g., *APQ12*, *LCB3*, *PEP12*, *PEX3*, *PMT2*, *SEC22*, *SNC1*, *SRO7*, *SUC2*, *SUR4*, *USE1*, and *YIP3*) were detected in both the ER and cytosolic fractions, with some, like *APQ12*, *LCB3*, *PEX3*, and *SNC1*, showing enrichment in the ER fraction ([Figure 2B](#F2){ref-type="fig"}). In contrast to these mSMPs, an mRNA that encodes a cytosolic serine hydrolase, *FSH3*, was found enriched in the cytosolic fraction ([Figure 2C](#F2){ref-type="fig"}). Thus not all RNAs are enriched with ER membranes. Similarly, non-mSMP RNAs that encode extralumenal membrane-associated proteins of the secretory pathway (e.g.. *SAR1*, *SEC9*, *YKT6*, and *YPT1*), as well as a control rRNA (*RDN18*), were found to be detected in both the ER and cytosolic fractions ([Figure 2D](#F2){ref-type="fig"}).

![mSMPs cofractionate with ER in WT cells. (A) Fractionation of lysates into ER (microsomal) and cytosolic fractions. WT yeast were lysed and subjected to sucrose density gradient centrifugation as described in *Materials and Methods*. Aliquots from the different fractions obtained through centrifugation were subjected to SDS--PAGE and detected in blots with antibodies against an ER marker, dolichol phosphate mannose (anti-Dpm1) synthase, or a cytosolic marker, phosphoglycerate kinase (anti-PGK1). Note lack of overlap between markers in the different fractions. (B) Distribution of mSMPs. Total mRNA isolated from the fractions (ER or cytosol \[Cyt\]) obtained using density gradient centrifugation was subjected to DNase I treatment and RT-PCR with oligonucleotide pairs specific to each mSMP. Genomic DNA served as a positive control for the PCR (Genomic), and RT without RNA template served as a negative control (--). PCR amplification of RNA from the ER and cytosolic fractions without reverse transcription (--RT) served as controls to detect DNA contamination. PCR amplification of RNA from the ER and cytosolic fractions with reverse transcription (+RT) is shown in duplicate. Samples were electrophoresed on agarose gels and documented by ethidium bromide labeling. (C) Distribution of an mRNA encoding a cytosolic protein. Same as in B except that an oligonucleotide pair specific to *FSH3* was used. (D) Distribution of mRNAs not encoding mSMPs. Same as in B except that oligonucleotide pairs specific to mRNAs encoding proteins not translocated into the ER, but instead associated either with the cytosolic leaflet of the secretory pathway (*SAR1*, *SEC9*, *SRO7*, *YKT6*, *YPT1*) or ribosome (*RDN18*) were used.](3069fig2){#F2}

In contrast to our imaging data, we did not see a significant enrichment of *SUC2* mRNA in the ER fraction derived from cells grown on high glucose (i.e., glucose-repressed cells). We noted, however, that glucose derepression is typically required for the induction of the secreted (signal peptide--containing) form of invertase. Thus we probably detected the RNA encoding only the nonsecreted isoform in this experiment ([Figure 2A](#F2){ref-type="fig"}). We therefore repeated the experiment using derepressed cells grown on 0.1% glucose and examined for the presence of *SUC2* mRNA. Under these conditions, we found that nearly all *SUC2* mRNA was associated with the ER fraction (Supplemental Figure S3). We also note that *USE1* and several other strongly ER-localized mRNAs ([Figure 1](#F1){ref-type="fig"}) were not enriched in the ER fraction ([Figure 2](#F2){ref-type="fig"}), which might indicate that the preparative procedure can have differential effects on RNA binding to the ER. Overall, however, both the microscopy and fractionation results shown here parallel earlier microarray studies demonstrating RNA association with the ER ([@B15]; [@B30]; [@B43]; [@B11]) and suggest that mSMPs target ER membranes (reviewed in [@B27]).

Endogenously expressed *SUC2* mRNA colocalizes with ER, as shown by single-molecule fluorescence in situ hybridization
----------------------------------------------------------------------------------------------------------------------

To further demonstrate that the presence of the MS2 aptamer does not affect (i.e., drive) RNA localization to the ER, we used single-molecule fluorescence in situ hybridization (smFISH; [@B53]) to examine the distribution of *SUC2* mRNA between the ER and cytosol. We used WT cells that express native *SUC2* mRNA (i.e., without the MS2 aptamer) from the genome or, as a negative control, cells lacking *SUC2* (*suc2Δ*), using low-glucose-containing medium to induce expression. On fixation and hybridization with multiple (20) nonoverlapping tetramethylrhodamine (TAMRA)-labeled oligodeoxynucleotide probes (22-mers) complementary to *SUC2*, we observed multiple small fluorescent dots that appeared similar to RNA granules, but only in the wild-type (WT) cells and not in the *suc2Δ* control. Scoring of the WT cells revealed that 85.7% of these labeled *SUC2* mRNA granules were associated with the ER ([Figure 3A](#F3){ref-type="fig"}), similar to the values obtained using the m-TAG MS2 system ([Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Thus both methods of detection indicate that *SUC2* transcripts localize preferentially to the ER, which, together with our subcellular fractionation studies ([Figure 2B](#F2){ref-type="fig"} and Supplemental Figure S3), confirms that presence of the MS2 aptamer does not confer transcript localization to the ER per se.

![*SUC2* mRNA colocalizes with ER using smFISH labeling. (A) Endogenous *SUC2* mRNA localizes to the ER using smFISH. WT and *suc2Δ* yeast expressing *SEC63-GFP* from a single-copy plasmid were grown to mid log phase and shifted to low glucose--containing medium for 1.5 h to induce *SUC2* expression. Cells were processed for smFISH labeling according to *Materials and Methods*, using nonoverlapping, TAMRA-labeled FISH probes complementary to *SUC2.* Labeling of *SUC2* mRNA (red fluorescence; *SUC2* \[FISH\]) was observed only in WT cells and colocalized mainly with Sec63-GFP fluorescence (ER). Merge (w/light), merger of the FISH, ER, and transmitted light windows. Bottom, scoring of *SUC2* mRNA localization, in terms of granules that localize to cortical ER, nuclear ER, both, or neither. (B) smFISH detects MS2-CP-GFP(x3)--labeled RNA granules. WT yeast bearing the *MS2L* aptamer sequence integrated into the *SUC2* locus (*SUC2~INT~*) were transformed with a plasmid expressing MS2-CP-GFP(x3), grown to mid log phase, induced on selective medium lacking methionine, and processed for smFISH. Cells were examined for smFISH labeling (red fluorescence; *SUC2* \[FISH\]) or MS2-CP-GFP(x3) labeling of the tagged transcript (green; *SUC2* \[MS2\]). Merge (w/light), merger of the smFISH, MS2, and transmitted light windows. Scale bar, 5 μm.](3069fig3){#F3}

Of interest, we observed more mRNA granules per cell using smFISH than typically seen using m-TAG. To compare the two techniques for mRNA visualization, we examined *suc2Δ* cells expressing MS2 aptamer--tagged *SUC2* from a single-copy plasmid, along with MS2-CP-GFP(x3), using both methods of detection. Under these expression conditions, we found that the smFISH probes detected all of the *SUC2* mRNA granules that could be detected with m-TAG ([Figure 3B](#F3){ref-type="fig"}). Additional smFISH-labeled granules were apparent, however, that were not labeled by the MS2 system. This is likely to indicate that smFISH is more sensitive than m-TAG (which we showed to label granules containing two or more tagged mRNAs; [@B23]), as expected. Alternatively, whereas smFISH should label mRNAs that are in the process of translation, it is likely that bound MS2-CP-GFP(x3) reporter proteins necessitate removal to allow for ribosome readthrough of tagged transcripts. Thus smFISH is likely to label transcripts that the MS2 system is unable to, and this could be yet another reason for the lower degree of granule detection.

Determination of the *cis* elements that control *SUC2* and *USE1* mRNA localization
------------------------------------------------------------------------------------

To investigate the elements that target mSMPs to the ER, we used the *USE1* and *SUC2* mRNAs as models for mSMPs encoding integral membrane proteins or soluble secreted enzymes, respectively. To do this, we expressed MS2 aptamer--tagged, full-length *SUC2* and *USE1* mRNAs (including their respective 3′UTRs) under the control of a methionine-starvation-inducible promoter from single-copy plasmids in wild-type cells. In addition, both MS2-CP-GFP(x3) and RFP-tagged Sec63 were coexpressed to visualize RNA and ER, respectively.

Because multiple studies show that the 3′UTR includes regulatory *cis* elements ([@B24]; [@B1]), we compared the level of ER localization of full-length *USE1* and *SUC2* (i.e., open reading frames \[ORFs\] + 3′UTRs) mRNAs versus mRNAs lacking their 3′UTRs (i.e., ORFs alone). We found that 81% of full-length *USE1* mRNA granules colocalized with RFP-Sec63--labeled ER ([Figure 4A](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}), which was similar to what was observed with endogenously expressed *USE1* mRNA (86% colocalization; [Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), whereas removal of the 3′UTR essentially did not change localization (79% colocalization; [Figure 4A](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). On the other hand, the ER localization of full-length *SUC2* mRNA colocalization was somewhat higher than with the endogenous message (92 vs. 81%) but was reduced (73% localization) upon removal of the 3′UTR ([Figure 4B](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Overall, however, it appears that the 3′UTR is not essential for the association of these mSMPs with ER.

![Role of sequence elements in *SUC2* and *USE1* colocalization with ER. (A, B) Four *MS2L*-tagged *USE1* or *SUC2* mRNAs (native full-length \[ORF + 3′UTR\]; lacking the 3′UTR \[ORF, no 3′UTR\]; bearing a mutated start codon \[ORF + 3′UTR, no ATG\]; lacking the 3′UTR and bearing a mutated start codon \[ORF, no 3′UTR, no ATG\]) were expressed from single-copy plasmids under the control of a methionine starvation--inducible promoter and examined for localization in WT cells by confocal microscopy. (A) Neither the 3′UTR nor translation initiation is required for the association of *USE1* mRNA with the ER. Representative confocal microscopy images of cells transformed with the different *MS2L*-tagged *USE1* plasmids (as labeled) and expressing MS2-CP-GFP(x3) and Sec63-RFP. Percentage of RNA granules that colocalize with ER (% Local.). mRNA, localization of GFP-labeled RNA granules; ER, localization of ER labeled with Sec63-RFP; mRNA/ER, merger of the ER and mRNA windows; Merge (All), merger between light, ER, and mRNA windows. Scale bar, 1 μm. (B) *SUC2* mRNA localization to the ER may be partially 3′UTR dependent but does not depend on translation initiation. Same as in A except that representative images of cells transformed with plasmids expressing the different *MS2L*-tagged *SUC2* plasmids (as labeled), as well as MS2-CP-GFP(x3) and Sec63-RFP, are shown. (C) The MS2 aptamer sequence also associates with the ER. Representative images of cells expressing the *MS2L* sequence without additional gene sequences, along with both MS2-CP-GFP(x3) and Sec63-RFP. Labeled as in *A.* (D) *FSH3* mRNA localizes to both the cytoplasm and ER. Representative images of cells expressing *MS2L*-tagged full-length *FSH3* (ORF + 3′UTR) from a single-copy plasmid under a methionine starvation--inducible promoter, along with MS2-CP-GFP(x3) and Sec63-RFP. Labeled as in A.](3069fig4){#F4}

###### 

*USE1* and *SUC2* mRNA localization to ER.

                                      Percentage of RNA granules colocalized with ER                       
  ----------------------------------- ------------------------------------------------ ------ ----- ------ ------
  *USE1* ORF + 3′UTR (full length)    14.0                                             61.0   6.0   19.0   81.0
  *USE1* ORF (no 3′UTR)               27.1                                             49.5   2.9   20.5   79.5
  *USE1* ORF + 3′UTR, no ATG          15.8                                             68.0   ---   16.2   83.8
  *USE1* ORF + 3′UTR, no ATGx2        50.1                                             18.6   1     30.3   69.7
  *USE1* ORF + 3′UTR, ∆TMD            21.6                                             53     7.2   18.2   81.8
  *USE1* ORF, ∆TMD                    32                                               43     7     18     82.0
  *SUC2* ORF + 3′ UTR (full length)   28.7                                             56.4   6.9   8      92.0
  *SUC2* ORF (no 3′ UTR)              21.9                                             48.5   2.8   26.8   73.2
  *SUC2* ORF + 3′UTR, no ATG          25                                               61.6   5     8.4    91.6
  *SUC2* ORF (no 3′ UTR), no ATG      25.5                                             42     4.1   28.2   71.6
  *SUC2* ORF + 3′UTR, ∆SS             22.8                                             53     3.3   20.9   79.3
  *SUC2* ORF (no 3′UTR), ∆SS          11.9                                             52.4   5.9   29.8   70.2
  *FSH3* ORF + 3′UTR (full length)    14.9                                             33.6   1.3   50.2   49.8
  *MS2L*                              7.3                                              54.8   3.6   34.3   65.7

Of interest, we noted that the polymeric MS2 aptamer sequence (*MS2L*; ∼750 bases; 12 loops) alone could colocalize to some degree with ER when detected with either MS2-CP-GFP(x1) (53% after 1 h of induction) or with MS2-CP-GFP(x3) (49% for uninduced cells vs. 66% after 1 h of induction; [Figure 4C](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Thus the MS2 aptamer sequence associates with the ER, although not with mitochondria (∼0% colocalization; data not shown). Because our smFISH and subcellular fractionation results clearly demonstrate that untagged mRNAs associate with ER microsomes ([Figures 2B](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}), however, we do not believe that the presence of the aptamer sequence is the means by which tagged transcripts localize with ER membranes. This does suggest, however, that naive RNAs target the ER by default, and this could indicate that ER membranes act as a trap for RNA molecules. Because *FSH3* mRNA was enriched in the cytosolic fraction ([Figure 2C](#F2){ref-type="fig"}), we examined its localization by aptamer tagging and fluorescence microscopy. We found that ∼50% of the RNA granules showed colocalization with ER ([Figure 4D](#F4){ref-type="fig"}). Therefore all large coding and noncoding (e.g., *RDN18* and *MS2L*) RNAs tested, as well as an RNA encoding a cytosolic protein (*FSH3*), appear to have some propensity to associate with ER membranes. As a consequence, we were unable to identify a negative control for the association of large RNAs to the ER, using either microscopy or cell fractionation.

Removal of the translation initiation codon does not alter *SUC2* and *USE1* mRNA localization to the ER
--------------------------------------------------------------------------------------------------------

According to the classic model, mSMPs target the ER in a translation-dependent manner via the SRP. Because all mSMPs examined colocalize with ER, we tested whether this association is translation dependent. First, we examined localization of the *USE1* and *SUC2* mRNAs lacking their start codon (in order to prevent translation). Because *USE1* also possesses an internal translation initiation site (nucleotides \[nts\] 211--213), we used a double mutant that lacks both the first and second ATG codons and cannot give rise to a functional Use1 protein (Supplemental Figure S4). We found that RNA granules of full-length *USE1* mRNA with both initiation sites (*USE1* ORF + 3′UTR, no ATGx2) still colocalized with the ER (70% colocalization; [Figure 4A](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Similarly, full-length *SUC2* mRNA lacking its start codon (*SUC2* ORF + 3′UTR, no ATG) showed 92% colocalization with the ER, whereas *SUC2* mRNA lacking both the start codon and 3′UTR (*SUC2* ORF, no 3′UTR, no ATG) gave 72% colocalization ([Figure 4B](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Thus removal of the translation initiation signal did not prevent the association of either *USE1* or *SUC2* message with the ER.

Of interest, Western analysis revealed production of a truncated, presumably intracellular, nonglycosylated form of Suc2 protein that lacks the signal peptide (encoded by the SSCR located between the first and second start codons; nts 4--57) from either the full-length *SUC2* mRNA construct lacking the first start codon or from *SUC2* in which the SSCR was removed (Supplemental Figure S5A). Thus either a block in translation of the encoded SSCR or its removal likely prevents interaction of the nascent peptide with SRP and leads to the accumulation of truncated Suc2 in the cytosol. To verify this further, we determined the enzymatic activities of plasmid-expressed, full-length Suc2, Suc2 lacking its first start codon, and Suc2 bearing a deletion in its SSCR in both lysed and nonlysed cells, which represent the intracellular versus secreted forms of invertase, respectively. By using a standard invertase assay (Supplemental Figure S5B), we found that essentially all invertase activity of *SUC2* lacking the first start codon or the SSCR was intracellular. In contrast, most of activity expressed from full-length *SUC2* was secreted. Therefore, although *SUC2* mRNA lacking the start codon localizes to the ER, it gives rise to a protein that cannot be secreted. This finding alone indicates that *SUC2* mRNA localization is likely to be SRP-independent.

Removal of the signal sequence--coding region of *SUC2* or transmembrane domain--coding region of *USE1* does not inhibit mRNA colocalization with ER
-----------------------------------------------------------------------------------------------------------------------------------------------------

The SRP recognizes the newly translated signal peptide or signal anchor sequence of type II membrane proteins emerging from ribosomes engaged in mSMP translation ([@B34]). To determine the necessity of the signal sequence and transmembrane domain (TMD)--coding regions for *SUC2* and *USE1* mRNA delivery to the ER, respectively, we expressed *SUC2* mRNA lacking its SSCR (*SUC2* ORF + 3′UTR ∆SS) and *USE1* mRNA lacking the encoded TMD (*USE1* ORF + 3′UTR ∆TMD) in wild-type cells. We could not, however, detect a reduction in ER localization for *USE1* mRNA either lacking the encoded TMD (82% ER localization) or both the TMD and the 3′UTR (*USE1* ORF \[no 3′UTR\] ∆TMD; 82% ER localization; [Figure 5A](#F5){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Similarly, removal of the SSCR had little effect on *SUC2* mRNA delivery to the ER. *SUC2* mRNA lacking the SSCR (*SUC2* ORF + 3′UTR ∆SS) showed 79% ER localization, whereas *SUC2* mRNA lacking both the SSCR and 3′UTR (*SUC2* ORF \[no 3′UTR\] ∆SS) showed 70% ER localization ([Figure 5B](#F5){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Thus neither the *SUC2* SSCR nor encoded *USE1* TMD appears essential for ER localization. More important, mSMP localization to the ER occurs despite removal of these elements and implies that mRNAs can be delivered in an SRP-independent manner.

![Localization of *SUC2* and *USE1* mRNAs to the ER is not dependent on the SSCR or TMD and is not sensitive to CHX treatment. (A) *USE1* colocalization with the ER does not depend on its TMD. Representative confocal microscopy images of WT cells expressing MS2-CP-GFP(x3), Sec63-RFP, and either *MS2L*-tagged *USE1* ORF + 3′UTR or ORF alone in which the TMD (*∆*TM) has been removed. Cells were grown overnight on liquid selective medium containing glucose and then shifted to the same medium lacking methionine for 1 h. Percentage of fluorescent RNA granules that colocalize with ER (% Local.). mRNA, localization of GFP-labeled RNA granules; ER, localization of ER labeled with Sec63-RFP; mRNA/ER, merger of the ER and mRNA windows; Merge (All), merger of the light, ER, and mRNA windows. Scale bar, 1 μm. (B) *SUC2* mRNA localizes to the ER after deletion of the SSCR. Representative WT cells expressing MS2-CP-GFP(x3), Sec63-RFP, and the *MS2L*-tagged ORF + 3′UTR or ORF alone in which the SSCR (∆SS) has been removed. Labeled as in A. (C) Endogenous *USE1* mRNA associates with the ER even on CHX treatment. Representative confocal microscopy images of cells expressing aptamer-tagged *USE1* from its genomic locus (*USE1~int~*), as well as MS2-CP-GFP(x3) and Sec63-RFP from plasmids. Cells were induced with medium lacking methionine 1 h before visualization, treated with 100 μg/ml CHX for 10 or 30 min, and immediately fixed. Labeled as in A. (D) Endogenous *SUC2* mRNA associates with the ER even on CHX treatment. Cells expressing aptamer-tagged *SUC2* from its genomic locus (*SUC2~int~*), as well as MS2-CP-GFP(x4) and Sec63-RFP from plasmids. Cells were grown and treated as in C, except that the medium contained 0.1% glucose (to induce *SUC2*).](3069fig5){#F5}

Cycloheximide treatment does not alter *SUC2* and *USE1* mRNA localization to the ER
------------------------------------------------------------------------------------

To verify translation-independent delivery of the *USE1* and *SUC2* mRNAs to the ER, we examined the localization of endogenously expressed, aptamer-tagged *USE1* and *SUC2* mRNAs in cells treated with the translation elongation inhibitor, cycloheximide (CHX). Aptamer-integrated cells grown to mid log phase were induced in medium lacking methionine (1 h) to express MS2-CP-GFP(x3) before CHX treatment. Because CHX induces cell cycle arrest ([@B14]), we initially examined its effect on wild-type cells. Within 1 h of treatment we detected an arrest in cell proliferation (data not shown). Because many of the cells were distorted morphologically by this time, however, we examined mRNA--ER colocalization at earlier time points (10 and 30 min after CHX treatment) using the aptamer-integrated cells. We found that *USE1* mRNA localization was not altered under these conditions, because treatment with CHX for either 10 or 30 min did not change ER localization (85% colocalization; [Figure 5C](#F5){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Similarly, *SUC2* mRNA colocalization with the ER was only very slightly effected by the CHX treatment, with 77% of RNA granules colocalized with the ER after 10 min and 75% colocalized after 30 min of CHX treatment ([Figure 5D](#F5){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). This result implies that either *SUC2* and *USE1* mRNAs are targeted to the ER in an essentially translation-independent manner or CHX treatment anchors the *SUC2*/*USE1* mRNA pool to the ER during the course of the experiment. Of interest, a shift in the distribution of *SUC2* RNA granules on the ER was observed, as the majority of granules (47%) were found on cER after CHX treatment, unlike in untreated cells, in which the majority of granules (42%) were found on nER. This change in granule distribution may represent a stress response to translation inhibition, since mRNAs have been shown to sequester on ER during stress instead of aggregating in stress granules ([@B26]). Finally, to verify that CHX-mediated translation inhibition occurred within the time frame of the RNA localization measurements, we incubated WT cells with CHX for 5 or 15 min, followed by a 15-min pulse with \[^35^S\]methionine to label newly synthesized proteins. CHX treatment led to the inhibition of protein synthesis, as almost no \[^35^S\]methionine label was incorporated into protein after as little as 5 min of treatment (Supplemental Figure S6).

Overall our results show that mSMPs like *SUC2* and *USE1* are retained on the ER even in the absence of elements crucial for translation initiation, SRP-dependent ER targeting, or integration into the membrane (TMD) and are resistant to the effects of translation inhibition by CHX. Thus mSMPs are likely to use translation- and SRP-independent routes to reach the ER.

Synthetic mRNAs target the ER without translation
-------------------------------------------------

[@B42]) demonstrated that mRNAs encoding membrane proteins have a higher uracil content (U-rich) than mRNAs encoding cytosolic proteins and that ∼60-nt coding stretches that contain ∼40% uracil residues invariably encode TMDs. This is because the codons for hydrophobic amino acids are U-rich, and this phenomenon is conserved from prokaryotes to eukaryotes. To investigate whether U-richness alone can promote RNA delivery to the ER in yeast, we expressed four MS2 aptamer--tagged synthetic nontranslatable RNA sequences and examined their localization in vivo. All RNA sequences expressed were ∼400 nt long, lacking both their ATGs and ribosome-binding sequences, and included stop codons before the U-rich regions (Supplemental Figure S7). Therefore these sequences are nontranslatable. We analyzed the following constructs: 1) MRL1, an RNA sequence based on bacterial *lac*Y that acts as a representative U-rich mRNA coding for a bacterial membrane protein; 2) MRL2, an RNA sequence based on bacterial *lac*Z that acts as a representative mRNA coding for a cytosolic protein; 3) MRL3, a U-rich random RNA sequence resembling a membrane protein ([@B42]); and 4) MRL4, a random RNA sequence that is U-poor (Supplemental Figure S7).

On induction in medium lacking methionine, these constructs typically yielded \>10 granules/cell (data not shown). Therefore, to avoid artifacts arising due to overexpression, we performed RNA localization without direct induction of MS2-CP-GFP(x3) (via expression due to leakiness of the *MET25* promoter), which led to ≤5 granules per cell. We observed that MRL1--3 could form detectable granules, whereas MRL4 was undetectable under these conditions. MRL1 granules showed a high level of colocalization with ER (85%), whereas MRL2 and 3 showed more moderate levels of colocalization (57 and 61% respectively; [Figure 6A](#F6){ref-type="fig"} and [Table 3](#T3){ref-type="table"}). Although ER localization of the MS2 aptamer (*MS2L*) alone was not insignificant and showed 49% colocalization under these conditions ([Figure 6A](#F6){ref-type="fig"} and [Table 3](#T3){ref-type="table"}), the experiment does reveal that nontranslatable mRNAs that do not bind ribosomes still reach the ER. In addition, U-rich MRL1 sequence localized preferentially to ER in comparison to its parallel U-poor cohort (MRL2). Because MRL4 granules could not be quantified, we could not compare MRL3 and MRL4. Nonetheless, the ability of MRL3, as well as the MS2 aptamer, to arrive at the ER implies that the ER may serve as a default destination for cellular mRNAs.

![Synthetic nontranslatable mRNAs localize to the ER, and SRP inactivation does not block RNA association with ER membranes. (A) Synthetic nontranslatable RNAs can target the ER. Representative confocal microscopy images of cells expressing *MS2L*-tagged synthetic nontranslatable mRNA sequences, *MRL1-3* (Supplemental Figure S5), or the MS2 aptamer (*MS2L*) alone, in cells coexpressing MS2-CP-GFP(x3) and RFP-Sec63. Cells were grown on liquid selective medium to mid log phase without induction in medium lacking methionine. Percentage of fluorescent RNA granules that colocalize with ER (% Local.). mRNA, localization of GFP-labeled RNA granules; ER, localization of ER labeled with Sec63-RFP; mRNA/ER, merger of the ER and mRNA windows; *Merge (All)*, merger of the light, ER, and mRNA windows. Scale bar,1 μm. (B, C) SRP inactivation does not block RNA association with ER membranes. (B) Fractionation of *sec65-1* cell lysates into ER (microsomal) and cytosolic fractions. Temperature-sensitive *sec65-1* cells expressing Sec63-GFP were grown to mid log phase on selective medium and maintained at 26°C or shifted for 6 h to 37°C. Cells were lysed and subjected to differential centrifugation to obtain protein and RNA as described in *Materials and Methods*. Protein aliquots from the different fractions obtained through centrifugation (ER-enriched membrane fraction \[ER\] and cytosolic fraction \[Cyt\]) were subjected to SDS--PAGE and detected in blots with antibodies against an ER marker, Sec63-GFP (*Sec63-GFP*; using anti-GFP antibodies), or a cytosolic marker, phosphoglycerate kinase (*PGK1*). (C) Distribution of mRNAs to ER microsomes and cytosol in *sec65-1* cells. After subcellular fractionation, RNA isolated from the different fractions (ER or Cyt) was subjected to DNase I treatment and RT-PCR with oligonucleotide pairs specific to each RNA (as indicated). Genomic DNA (Gen) served as a positive control for the PCR, and reverse transcription without an RNA template served as a negative control (--). PCR amplification of RNA from the ER and cytosolic fractions without reverse transcription (--RT) served as controls to detect DNA contamination. PCR amplification of RNA from the ER and cytosolic fractions with reverse transcription (+RT) is shown in duplicate. Samples were electrophoresed on agarose gels and documented by ethidium bromide labeling.](3069fig6){#F6}

###### 

Localization of synthetic nontranslatable RNAs to the ER.

         Percentage of RNA granules colocalized with ER                       
  ------ ------------------------------------------------ ------ ----- ------ ------
  MRL1   13.6                                             62.0   9.0   15.4   84.6
  MRL2   11.4                                             42.6   3.3   42.7   57.3
  MRL3   21.0                                             40     ---   39     61.0
  MS2L   13.8                                             33.8   1.5   50.9   49.1

Expression was not induced by medium lacking methionine

SRP inactivation does not lead to a decrease in mRNA localization to the ER
---------------------------------------------------------------------------

To obtain additional proof of SRP-independent mRNA delivery to the ER, we examined the distribution of endogenously expressed *SUC2*, *SNC1*, and *SUR4* mRNAs in *sec65-1* temperature-sensitive SRP mutant cells (RSY457 strain; Supplemental Table S1) under conditions in which SRP is inactivated (incubation at 37°C). First, to both monitor and verify SRP inactivation, we analyzed *sec65-1* cells expressing DsRed bearing a Kar2 signal sequence at the N-terminus and an HDEL Golgi--ER retrieval sequence (Kar2SS-DsRed-HDEL) that allows for the fusion protein to enter into and remain within the ER. At 26°C we observed Kar2SS-DsRed-HDEL to reside within the ER. On *sec65-1* inactivation at 37°C, we observed its time-dependent localization in the cytosol, indicating blocked entry into the ER (Supplemental Figure S8). Next we fractionated both temperature-shifted and nonshifted *sec65-1* cells into cytosolic and ER fractions ([Figure 6B](#F6){ref-type="fig"}) and examined them for the presence of RNAs using RT-PCR ([Figure 6C](#F6){ref-type="fig"}). We found that *SEC65* inactivation did not alter the distribution of *SNC1* and *SUR4* mRNAs, whereas the level of *SUC2* mRNA localization to the cytosol greatly decreases. We observed a similar result for the *RDN18* rRNA. Thus SRP inactivation does not appear to be involved in the localization of these RNAs to the ER.

Involvement of RNA-binding proteins in targeting of *SUC2* and *USE1* mRNA
--------------------------------------------------------------------------

Because several RBPs affect RNA localization to yeast ER ([@B19]; [@B2]; [@B12]), we determined their contribution to delivery of the *SUC2* and *USE1* mRNAs to the ER. We deleted genes encoding RBPs that were reported to either bind mSMPs (e.g., Puf1/2, Whi3) or be involved in ER targeting (e.g., She2) in the aptamer-integrated *USE1* and *SUC2* strains. We found that *USE1* mRNA remained localized to ER in all of the deletion mutants, although we observed a slight decrease in *puf2Δ* cells ([Figure 7A](#F7){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Deletion of either *SHE2* or *PUF2*, however, significantly reduced the localization of *SUC2* mRNA with ER (60 and 62%, respectively, vs. 81% in wild-type cells; [Figure 7B](#F7){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). To assess whether the deletion of both *SHE2* and *PUF2* could have a cumulative effect, we scored the localization of *SUC2* mRNA in *puf2Δ she2Δ* cells. We observed decreased *SUC2* mRNA localization to the ER in these cells (54%; [Table 1](#T1){ref-type="table"}), but in comparison to the individual deletions, this effect did not appear to be additive. In contrast, the deletion of *PUF1* or *WHI3* did not significantly change *SUC2* mRNA colocalization with ER (75.6 and 80.7% respectively; [Figure 7B](#F7){ref-type="fig"} and [Table 1](#T1){ref-type="table"}).

![Localization of *USE1* and *SUC2* mRNAs in cells lacking ER-associated RBPs. (A) Localization of *USE1* mRNA in cells lacking ER-associated RBPs. Representative images of endogenously expressed *MS2L*-tagged, full-length *USE1* mRNA in WT, *she2Δ*, *puf1Δ*, *puf2Δ*, or *whi3Δ* cells coexpressing MS2-CP-GFP(x3) and Sec63-RFP. Cells were grown on selective medium to mid log phase without induction in medium lacking methionine. Percentage of fluorescent RNA granules that colocalize with ER (% Local.). mRNA, localization of GFP-labeled RNA granules; ER, localization of ER labeled with Sec63-RFP; mRNA/ER, merger of the ER and mRNA windows; Merge (All), merger of the light, ER, and mRNA windows. Scale bar, 1 μm. (B) Localization of *SUC2* mRNA in cells lacking ER-associated RBPs. Representative images of endogenously expressed, *MS2L*-tagged *SUC2* mRNA in WT, *she2Δ*, *puf1Δ*, *puf2Δ*, or *whi3Δ* cells coexpressing MS2-CP-GFP(x3) and Sec63-RFP. Cells were grown on synthetic selective medium and then shifted to low glucose (0.1%)--containing medium lacking methionine for 1 h. Labeled as in A.](3069fig7){#F7}

Although *SUC2* mRNA is not polarized to the daughter cells, like *ASH1* and POL mRNAs, its localization to the ER was affected in *she2Δ* cells. By comparison to the known consensus sequence for She2 binding ([@B39]), we found a potential She2-binding site in the *SUC2* coding region (base pairs 280--345) that might serve as a *cis-*acting element. We then verified whether *SUC2* mRNA is indeed bound to She2, by expressing Myc-tagged She2 in wild-type cells that were shifted to low (0.1%) glucose for 2 h, followed by immunoprecipitation with anti-Myc antibodies (Supplemental Figure S9). Along with *ASH1* mRNA, *SUC2* mRNA was also detected by RT-PCR specifically in cells expressing Myc-She2 but not the control vector alone (Supplemental Figure S9A). Similarly, Myc-She2 could be detected only in immunoprecipitates derived from cells expressing *MYC-SHE2* and not from the control cells (Supplemental Figure S9B). Thus, upon its induction, endogenous *SUC2* mRNA is likely to be transported with *ASH1* mRNA in the same RNA granule.

In summary, our results suggest the existence of translation-independent delivery of mRNAs to the ER, which is regulated by both *cis*-acting sequence elements and *trans*-acting protein partners.

DISCUSSION
==========

Multiple studies have demonstrated SRP-dependent delivery of mSMPs to ER membranes in vitro; however, this path necessitates translation as the preliminary step that promotes SRP binding and cotransport of the translating ribosome and SRP complex to the ER ([@B47]). Studies that use biochemical fractionation followed by microarray analysis already demonstrated the existence of numerous mRNAs, both mSMPs and mRNAs encoding cytosolic proteins, on the ER ([@B30]; [@B43]; [@B11]). Thus the question remains open of whether translation and SRP involvement are absolutely required for mRNA association with ER.

In this study, we localized in vivo 11 endogenously expressed yeast mSMPs (*ALG1*, *GOS1*, *ICE2*, *NYV1*, *PEP12*, *PMT2*, *SEC22*, *SUC2*, *SUR4*, *USE1*, and *YIP3*) and two non-mSMP RNAs that encode soluble proteins that act from the cytosol upon the secretory pathway (*SEC9*, *SEC20*) using m-TAG ([Figure 1](#F1){ref-type="fig"}). All of these mRNAs colocalized to a large degree with the ER, whereas some preference was demonstrated for either nER (*PMT2*, *SUC2*, *SUR4*, *USE1*, and *YIP3* mRNAs) or cER (*GOS1*, *NYV1*, *PEP12*, *SEC9* and *SEC22* mRNAs; [Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Because none these mRNAs or their encoded proteins are polarized (i.e., to the bud tip, where polarized mRNAs, POL proteins, and cER colocalize; [@B2]; [@B18]), it is unclear how or why such a preference might exist. That said, however, we note that mSMPs encoding tail-anchored SNARE proteins (*GOS1*, *NYV1*, *PEP12*, *SEC22*), which likely use the GET pathway for insertion into the ER membrane ([@B46]), appear to show a preference for the cER. This might suggest that some areas of the ER have different properties that could potentiate the import and localization of tail-anchored proteins. We also note that aptamer-tagging and RNA visualization revealed that several mRNAs, including *NYV1*, *SEC22*, *SEC20*, a control mRNA encoding a cytosolic protein, *FSH3*, and even the *MS2L* aptamer, showed a roughly equal distribution between the ER and cytoplasm ([Figures 1](#F1){ref-type="fig"} and [4, C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}, and [Table 1](#T1){ref-type="table"}). Moreover, the MS2 imaging data were verified by subcellular fractionation, in which the different (nontagged) mRNAs examined all fractionated to some extent between both the ER and cytosolic fractions ([Figure 2B](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Similarly, we demonstrated, using smFISH, that a nontagged transcript (*SUC2*) colocalized to the same degree with the ER as an MS2 aptamer--tagged *SUC2* transcript using m-TAG ([Figure 3A](#F3){ref-type="fig"}). Thus the presence of the MS2 aptamer sequence neither is necessary nor appears to enhance mRNA localization to the ER. Moreover, the results shown here validate previous cell fractionation and microarray studies showing that numerous mRNAs are associated with ER membranes ([@B15]; [@B30]; [@B43]; [@B11]) and suggest that all RNAs, either coding or noncoding (e.g., *RDN18*, *MS2L*), have some inherent propensity to interact with ER membranes.

By using the *SUC2* and *USE1* mRNAs as a representative mSMPs encoding for secreted ([@B40]) and TMD-containing proteins ([@B16]), respectively, we further investigated mRNA targeting to the ER. Although the targeting of *USE1* mRNA was unaffected by removal of its 3′UTR, that of *SUC2* mRNA showed a modest reduction (∼20 percentage point change) in localization that effectively resulted in a threefold increase in the level of RNA mislocalization to the cytoplasm ([Figure 4](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). This suggests that the 3′UTR of *SUC2* contains *cis* elements that may contribute to ER localization. No other mutation (e.g., removal of the translation initiation codon or SSCR) alone was found to affect *SUC2* mRNA localization significantly, and combinations of these mutations (along with removal of the 3′UTR) were not additive ([Table 2](#T2){ref-type="table"}). Similarly, *USE1* colocalization with the ER was robust, and no mutation---not even removal of the TMD or start codons---could abolish this ([Figure 4A](#F4){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). Of interest, the mammalian orthologue of Use1, p31, is required for the maintenance of tubular ER structures (cER) and cell survival ([@B50]). ER morphology is abnormal in p31-knockout mouse embryo fibroblasts, resulting in impaired protein transport and disorganization of the ER, which leads to ER stress and apoptosis. Thus, besides being an essential SNARE, Use1 could serve as a regulator of ER tubules and their integrity. This suggests that the ER localization of mRNAs encoding Use1 and other tail-anchored proteins (e.g., Gos1, Nyv1, Pep12, and Sec22) may enhance the likelihood of their translation products encountering GET-complex components and undergoing insertion into the membrane. Moreover, any secondary role these proteins have in maintaining tubular ER structures would also necessitate correct placement into the cER, which seems be a preferred site for the localization of their mRNAs ([Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Future studies are necessary to decipher the *cis* elements responsible for localization of mRNAs encoding tail-anchored proteins.

In addition to using the *SUC2* and *USE1* mRNAs to dissect the sequence elements involved in ER localization, we examined whether their delivery is translation-dependent. Several lines of evidence suggest that translation is not obligatory for mRNA targeting to the ER. First, endogenous *SUC2* and *USE1* mRNA could localize within the proximity of the ER after treatment with the translation inhibitor CHX ([Figure 5, C and D](#F5){ref-type="fig"}, and [Table 1](#T1){ref-type="table"}). Similarly, treatment with puromycin or pactamycin, two other translation inhibitors, did not disrupt the association of mRNAs encoding either cytosolic proteins or ER-targeted proteins in mammalian cells ([@B30]; [@B43]). Second, both *USE1* and *SUC2* mRNAs bearing mutations in their translation initiation sites still localized to the ER ([Figure 4, A and B](#F4){ref-type="fig"}). In the case of *SUC2* mRNA, this led to the appearance of a truncated cytosolic form of invertase (Supplemental Figure S5), which indicates that not only translation, but even the association with SRP, is not requisite for RNA localization. This idea is supported by the fact that deletion of the SSCR of *SUC2* (which prevents *SUC2* mRNA association with the SRP-ribosome complex and thereby abolishes cotranslational delivery) had only a small effect on ER targeting ([Figure 5B](#F5){ref-type="fig"}). Moreover, cell fractionation studies using membranes derived from a temperature-sensitive mutant of the Sec65 SRP subunit demonstrated that *SUC2* mRNA remains ER associated even on SRP inactivation ([Figure 6C](#F6){ref-type="fig"}). Thus our work supports the idea of translation- and SRP-independent mRNA localization to ER membranes. Consistent with these findings, others have shown that deletion of the encoded SSCR of *GRP94*, an mRNA enriched at the ER, inhibits only delivery of the protein and not the message to the ER in Cos-7 cells ([@B43]). Correspondingly, knockdown of the essential 54-kDa subunit of the SRP in HeLa cells did not alter mRNA delivery to the ER ([@B43]). Finally, a recent study demonstrated translation- and ribosome-independent localization of a subset of RNAs and identified an ER membrane protein, p180, as a putative mRNA receptor ([@B13]). Thus results from a wide variety of systems and sources all indicate the existence of alternative translation- and SRP-independent paths for mRNA delivery to the ER.

Overall, numerous studies by Nicchitta and colleagues ([@B15]; [@B30]; [@B43]; [@B11]; [@B44]) demonstrated that mRNAs coding for cytosolic and secretory proteins can partition to the ER in both a ribosome-dependent and -independent manner. Of interest, biochemically distinct modes of mRNA association with the ER can be ascribed ([@B11]). For example, mRNAs encoding secreted proteins dissociate from the membrane faction under conditions that release ribosomes (high salt/EDTA treatment), whereas mRNAs coding for resident ER proteins have a tighter level of membrane binding and remain attached under the same conditions ([@B11]). Although we modeled the localization of mRNAs encoding secreted (*SUC2*) and ER-resident (*USE1*) proteins, we did not examine the strength of their association with membranes. Nevertheless, our results imply that *USE1* mRNA delivery to the ER is translation-independent, whereas that of *SUC2* mRNA is translation-, SSCR-, and SRP-independent. Therefore RNA localization to the ER is likely to be ribosome independent in both cases.

One additional measure we used to verify that translation is not required for mRNA delivery to the ER was to examine the localization of mRNAs that cannot engage and be translated by ribosomes (e.g., MRL1-3; [Figure 6A](#F6){ref-type="fig"}). Of importance, these mRNAs also colocalized strongly with ER, which indicates both that their delivery is translation-independent and even prokaryote-based sequences undergo targeting within eukaryotic cells. According to the work of [@B42], mRNAs that encode integral membrane proteins are highly U-rich (in the TMD-coding region). By comparing a U-rich sequence (MRL1) and a U-poor one (MRL2), we found that the former showed a greater preference for the ER. This suggests that U-rich sequences could serve as *cis*-acting elements for ER targeting.

We found that all mSMPs, along with mRNAs encoding soluble SNAREs (which lack a signal sequence or TMD), which localize to the cytosolic aspect of the secretory pathway, showed a robust ability to associate with ER ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Because the noncoding MS2 aptamer MS2L and nontranslatable synthetic message MRL3 also localized to ER, this suggests that this organelle is both a general anchoring site for RNA and, perhaps, a default sorting center for RNA after nuclear export, although it is important to stress that not all RNAs target the ER directly ([@B51]; [@B17]). In support of this idea, our lab recently demonstrated that a mutant form of *OXA1* mRNA, which encodes a mitochondria-localized protein, that lacked both its 3′UTR and translation initiation codon was mislocalized to nER ([@B17]). Thus *OXA1* mRNA mislocalizes to the ER in the absence of normal mitochondrial targeting information. Another reason for the high abundance of mRNA on the ER is that ER anchoring enables transcripts to be cotransported efficiently to the bud ([@B20]). Therefore RNA--ER associations likely allow not only for the efficient import of protein into the ER, but also for localized translation/translocation at distal regions of the cell.

In addition to the *cis* elements involved in RNA targeting, *trans*-acting RBPs involved in the binding of mSMPs have been identified in various organisms (reviewed in [@B27]). In *Saccharomyces cerevisiae*, several RBPs (Puf1, Puf2, Whi3, She2, Scp160) bind mSMPs, although in this work we could not find one that regulates *USE1* mRNA targeting to the ER. We were able to see, however, a modest effect of She2 and Puf2 on the localization of *SUC2* mRNA and verified that endogenous *SUC2* mRNA immunoprecipitates with She2 ([Figure 6C](#F6){ref-type="fig"}, [Table 1](#T1){ref-type="table"}, and Supplemental Figure S9). Although a double deletion of *PUF2* and *SHE2* did not lead to an additive decrease in *SUC2* mRNA localization ([Table 1](#T1){ref-type="table"}), it may be that functional redundancy between these different RBPs (Puf1/2, Whi3, and She2) results in the minimal effects observed on mSMP targeting and cell viability upon their deletion. Further studies involving the affinity purification of these mRNAs are needed to determine what *trans* factors specifically contribute to SRP-independent mRNA targeting to ER.

According to the classic model, mRNAs are targeted to the ER in an SRP- and translation-dependent manner ([@B47]), and, although other pathways have recently been suggested to regulate the import of signal sequence-containing proteins ([@B3]), no translation-independent mechanism for RNA delivery to the ER has been put forth. Although our results do not preclude translation-dependent mRNA delivery, it is highly apparent that RNAs can use alternative means (as proposed in [@B5], [@B6]; [@B11]) to associate with membranes in a translation-independent manner. Our work strongly supports the idea of translation-independent mRNA targeting to the ER in eukaryotes, and, although the mechanism is unclear, it probably involves *cis*-element recognition by *trans*-acting RBPs.

MATERIALS AND METHODS
=====================

Yeast strains, growth conditions, and mRNA imaging
--------------------------------------------------

Supplemental Table S1 lists yeast strains used in this study. Yeast were grown to mid log phase in standard rich growth medium containing either 2% glucose (YPD) or synthetic medium containing glucose (synthetic complete \[SC\] and selective SC drop-out medium lacking an amino acid or nucleotide base). For fluorescence microscopy, the induction of MS2-CP fused to three GFPs (MS2-CP-GFP(x3)) was performed by growing yeast strains in synthetic selective medium to mid log phase, followed by a shift to the same medium lacking methionine for 1 h at 26°C before visualization by confocal microscopy. For the induction of MS2-CP-GFP(x4), cells were either maintained on synthetic selective medium (in which some MS2-CP-GFP expression occurs due to leakiness of the *MET25* promoter) to minimize reporter expression and aggregation or induced for 1 h in the same medium lacking methionine. Aptamer-integrated *SUC2* cells were grown to mid log phase on selective synthetic medium containing 0.1% glucose and shifted to the same medium lacking methionine for 1 h. Cells were then collected and fixed in a solution containing 4% (wt/vol) paraformaldehyde and 4% (wt/vol) sucrose and taken directly for imaging. Representative images were acquired using either a Zeiss LSM510 Meta confocal microscope (Carl Zeiss, Jena, Germany) and a Plan Apo 100×/oil objective or a LSM710 Meta and a Plan Apo 63×/oil objective. The following wavelengths were used: for GFP, excitation at 480 nm and emission at 530 nm; for monomeric RFP, excitation at 545 nm and emission at 560--580 nm. Colocalization of MS2 aptamer--tagged mRNAs with ER was performed using cells that coexpressed Sec63-RFP. mRNA granule localization was scored in 50--100 cells for each tagged RNA. At least two individual transformants for any given mRNA were used for statistical analysis. [Table 1](#T1){ref-type="table"} shows statistics for the percentage of granules that colocalized with ER.

Plasmids and DNA manipulation
-----------------------------

Plasmid pSL1180, which bears 12 loops of the viral MS2-CP binding site, was provided by R. Singer (Albert Einstein College of Medicine, Bronx, NY). Plasmid pSM1960, which expresses Sec63-RFP, was provided by S. Michaelis (Johns Hopkins University, Baltimore, MD). Plasmid pSH47, which expresses Cre recombinase from a galactose-inducible promoter, was obtained from the European *Saccharomyces cerevisiae* Archive for Functional Analysis (Frankfurt, Germany). Plasmid pLOXHIS5MS2L was used to generate integration constructs for genomic insertion of the MS2 aptamer by PCR, as described in the m-TAG procedure ([@B23]; [@B21]). Plasmid pMS2CPGFP(x3), which expresses MS2-CP-GFP(x3), and pMS2CPGFP(x4), which expresses MS2-CP-GFP(x4), were previously described ([@B23]; [@B51]). Plasmids expressing *MS2L*-tagged *SUC2*, *USE1*, or *FSH3* were created using a modified pUG36 plasmid, pUG36w/oGFP, lacking the *GFP* gene (removed using *Xba*I and religated). Next a *Bam*HI-*Bgl*II fragment containing the MS2 loop sequence was excised from pSL1180 and ligated to the *Bam*HI site of pUG36w/oGFP, followed by blunt-ending and ligation to the *Sma*I site to yield pUG36MS2L. Next the *SUC2* and *USE1* ORFs were amplified by PCR using primers bearing the *Spe*I restriction site and inserted into the *Spe*I site of the polylinker of pUG36MS2L to yield plasmids pSUC2MS2L and pUSE1MS2L, respectively. The *FSH3* ORF was amplified by PCR using primers bearing the *Bgl*II restriction site and inserted into the *BamH*I restriction site of pUG36MS2L to yield pFSH3MS2L. The *SUC2* and *USE1* 3′UTRs (500 base pairs) were amplified by PCR using primers bearing *Xho*I restriction sites and cloned into the *Xho*I site of pSUC2MS2L and pUSE1MS2L to yield plasmids pSUC2MS2L+3′UTR and pUSE1MS2L+3′UTR, respectively. The *FSH3* 3′UTR (600 base pairs) was amplified by PCR using primers bearing *Xho*I and *Hin*dIII restriction sites and cloned into the *Xho*I and *Hin*dIII restriction sites of pFSH3MS2L to yield plasmid pFSH32MS2L+3′UTR. Plasmids pSUC2MS2L+3′UTR-ATGmut and pUSE1MS2L+3′UTR-ATGmut, which express *MS2L*-tagged full-length *SUC2* or *USE1* mRNAs bearing mutations in the first ATG of *SUC2* and *USE1*, respectively, were created using *Pfu* DNA polymerase, specific mutagenic primers, and plasmids pSUC2MS2L+3′UTR or pUSE1MS2L+3′UTR as templates, respectively. Plasmid pUSE12MS2L+3′UTR-ATGx2mut, which expresses *MS2L*-tagged full-length *USE1* mRNA bearing mutations in both the first and second ATGs, was created using *Pfu* DNA polymerase, specific mutagenic primers, and plasmid pUSE1MS2L+3′UTR-ATGmut as template. Plasmid pMS2LSUC2-ATGmut, which expresses *MS2L*-tagged *SUC2* mRNA lacking its 3′UTR and bearing a mutation in the initial ATG, was created using *Pfu* DNA polymerase, specific mutagenic primers, and plasmid pSUC2MS2L as a template. Plasmids pSUC2MS2L+3′UTR-SS∆ and pSUC2MS2L-SS∆, which lack the *SUC2* SSCR (nucleotides 4--57), were created using *Pfu* DNA polymerase, specific deletion primers, and plasmids pSUC2MS2L+3′UTR and pSUC2MS2L as templates, respectively. Plasmids pUSE1MS2L+3′UTR-TM∆ and pUSE1MS2L-TM∆ lacking the *USE1* TMD-coding region (nucleotides 655--717) were created using *Pfu* DNA polymerase, specific deletion primers, and plasmids pUSE1MS2L+3′UTR and pUSE1MS2L as templates, respectively. Plasmids pMRL1-MS2L, pMRL2-MS2L, pMRL3-MS2L, and pMRL4-MS2L were created by amplifying sequences MRL1--4 (Supplemental Figure S6) from a bacterial vector (pUC57) by PCR. Amplification products were digested with *Bam*HI and ligated into pUG36w/oGFP to yield the foregoing plasmids. All constructs were verified by DNA sequencing. Supplemental Table S2 lists the primers.

To evaluate the role of Whi3, Puf1, Puf2, and She2 in *USE1* and *SUC2* mRNA localization, the genes were deleted in the corresponding MS2 aptamer--integrated *SUC2* and *USE1* strains using deletion constructs as described in [@B17]).

Genomic integration of the MS2 aptamer sequence
-----------------------------------------------

For each gene to be tagged with the MS2 aptamer, a forward oligonucleotide complementary to the 3′-end of the coding region (overlapping by ∼40 base pairs including stop codon) and 5′-end of the *loxP::Sphis5+::loxP::MS2L* cassette was used, along with a reverse oligonucleotide complementary to the 3′UTR (by ∼40 base pairs) and 3′-end of the *loxP::Sphis5+::loxP::MS2L* cassette, in the PCR with pLOXHIS5MS2L as the template ([@B23]; [@B21], [@B22]). PCR products of the correct size were transformed into yeast and grown on plates containing SC medium lacking histidine for 3--5 d at 26°C. To confirm integration, genomic DNA was extracted from single colonies, and PCR amplification, using a forward primer complementary to the coding region and reverse primer complementary to the *loxP::Sphis5+::loxP::MS2L* cassette and 3′UTR, was performed. PCR products were sized on agarose gels and sequenced for verification. Yeast bearing correct *loxP::Sphis5+::loxP::MS2L* integrations were transformed with plasmid pSH47 and grown on SC medium lacking histidine and uracil. Cre recombinase expression was induced by growing transformed cells in SC medium containing 3% galactose and lacking uracil for 16 h at 26°C. Cells were then diluted, plated, and grown on SC medium lacking uracil and replica plated to determine the presence or absence of the *Sphis5+* auxotrophic marker. Yeast bearing the *loxP::MS2L* integration (∼790 base pairs including *loxP* and *MS2L*) were verified by PCR amplification (using oligonucleotides complementary to the coding region and 3′UTR, respectively) and DNA sequencing. MS2-CP binding sites (*MS2L*) were integrated into wild-type yeast between the coding region and 3′UTR of the genes.

Subcellular fractionation and protein/RNA detection
---------------------------------------------------

Separation of the ER and cytosol was performed using two methods. Microsome fractionation using the first method was performed as described in [@B2]. In brief, wild-type BY4743Hα yeast were grown at 26°C in selective medium (400 ml) to OD~600~ of 0.6. Cycloheximide was added to a final concentration of 100 μg/ml, and cultures were grown for another 15 min at 26°C. Cells were harvested and washed with ice-cold SK buffer (1.2 M sorbitol, 0.1 M KPO~4~, pH 7.5, and 100 μg/ml cycloheximide). After 5 min of incubation on ice, cells were centrifuged for 3 min at 500 × *g*, mechanically disrupted in liquid nitrogen using a mortar and pestle, and resuspended in 1 ml of ice-cold lysis buffer. Lysates were further homogenized using 30 slow strokes with an ice-cold Dounce homogenizer. Crude total cell lysates (TCLs) were obtained by centrifugation for 5 min at 500 × *g*. Lysates (900 μl total volume each) were then equilibrated with a solution of 5.37 ml of 2.5 M sucrose, 190 μl of 3 M KCl, and 40 μl of 1 M Tris, pH 7.5, to yield a final concentration of 2.1 M sucrose. Next a discontinuous sucrose gradient was formed by adding consecutive layers of 2.5 M (volume, 2 ml), 2.1 M (volume, 6.25 ml; the sucrose-equilibrated cell lysate), 2 M (volume, 6.25 ml), and 1.3 M (volume, 2 ml) sucrose, respectively, in a 17-ml ultracentrifuge tube. Gradients were centrifuged at 25,000 rpm (90,000 × *g*) in an SW32 rotor (Beckman Coulter, Indianapolis, IN) at 4°C for 12 h. Next 400-μl samples were collected, and total RNA from the membrane interface (interface between 1.3 and 2.05 M sucrose layers) and cytosolic fraction (2.1 M sucrose layer) was isolated using a MasterPure Yeast RNA Purification Kit (including DNase I treatment) according to manufacturer\'s recommendations (Epicentre Biotechnologies, Madison, WI).

The second method is based on ultracentrifugation of total cell lysates for 1 h at 48,000 × *g*, with subsequent analysis of RNA extracted (as described) from supernatant and pellet, corresponding to cytosol and ER, respectively. This method was used to analyze the distribution of *SUC2* mRNA in both repressed and derepressed cells, as well as to analyze RNA distribution in the *sec65-1* temperature-sensitive strain at both permissive and restrictive temperatures. In brief, WT BY4743Hα cells expressing *SEC63-GFP* from a single-copy plasmid (as an ER marker) were grown at 26°C in selective medium (400 ml) to OD~600~ of 0.6. Cycloheximide was added to a final concentration of 100 μg/ml, and cultures were grown for another 15 min at 26°C. Cells were harvested and washed with ice-cold SK buffer. After 5 min of incubation on ice, cells were centrifuged for 3 min at 500 × *g*, resuspended in a buffer solution containing 50 mM Tris (pH 7.6), 150 mM NaCl, 200 U of RNasin Ribonuclease Inhibitor (Promega, Madison, WI), Complete Protease Inhibitor Cocktail (Roche Diagnostics, Basel, Switzerland), and cycloheximide 100 μg/ml, and disrupted using glass beads and vortexing for 10 min at 4°C. Crude lysates were centrifuged for 10 min at 1000 × *g* to remove cell debris, and then 1 ml of each lysate was subjected to ultracentrifugation for 1 h at 48,000 × *g*. The resulting pellet was then resuspended in 500 μl of buffer containing 50 mM Tris (pH 7.6), 150 mM NaCl, 80 U/ml RNasin Ribonuclease Inhibitor, Complete Protease Inhibitor Cocktail, and 100 μg/ml cycloheximide. Next total RNA from both the membrane fraction (resuspended pellets) and the cytosolic fraction (supernatants) was isolated using the MasterPure Yeast RNA Purification Kit (including DNase I treatment) according to the manufacturer\'s recommendations.

For each method of cell fractionation performed, reverse transcription (RT) was performed using Moloney murine leukemia virus RT RNase H(--) (Promega) under conditions suggested by the manufacturer. For each mRNA to be detected, the RT reaction was performed for the same quantity of total RNA (2.5 μg). cDNA used for PCR amplification was tested by serial dilution in order to avoid reaching a plateau phase (saturation) during PCR. Specific oligonucleotide pairs were then used to amplify genes of interest. For each mRNA to be tested, the same quantity of cDNA from the RT reaction was taken from both the ER and cytosolic fractions for PCR. Negative controls (PCR amplification of RNA from ER and cytosolic fractions without RT or PCR without template) were performed in parallel and yielded no products after PCR, with PCR on genomic DNA serving as positive control. Samples of the PCR products were electrophoresed on 1% agarose gels and documented. To detect proteins by immunoblotting, 25 μg of protein from the ER and cytosolic fractions was subjected to SDS--PAGE on 7 or 10% acrylamide gels. Immunoblots were blocked in 5% nonfat milk in phosphate-buffered saline and incubated with a polyclonal anti-DPM1 antibody (1:1000; Molecular Probes, Eugene, OR) to detect the ER and either anti--phosphoglycerate kinase antibody (diluted 1:1000; gift of Z. Elazar, Weizmann Institute of Science, Rehovot, Israel) or monoclonal anti-GFP antibodies (Roche Diagnostics) to detect cytosolic Pgk1 or GFP-Sec63, respectively. Rabbit polyclonal antibodies against Kar2 (diluted 1:5000) and Tom70 (diluted 1:10,000), used to detect ER and mitochondria, respectively, were gifts from M. Schuldiner (Weizmann Institute of Science) and Y. Arava (Technion, Haifa, Israel).

smFISH
------

Yeast cells were grown to OD~600~ of 0.1--0.2 at 26°C. Induction of endogenous *SUC2* expression was performed by shifting the cells to rich (YPD) medium containing 0.1% glucose for 1.5 h. Plasmid-based expression of *SUC2* under *MET25* promoter was induced by shifting the cells on selective synthetic medium without methionine for 1.5 h. After *SUC2* induction, cells were fixed in the same medium with added formaldehyde (3.7% final concentration) for 45 min. Cells were gently washed twice with 0.1 M potassium phosphate buffer, pH 7.4, containing 1.2 M sorbitol, after which cells were spheroplasted in 1 ml of a freshly prepared spheroplast buffer (0.1 M potassium phosphate buffer, pH 7.4, 1.2 M sorbitol, 20 mM ribonucleoside vanadyl complexes \[Sigma-Aldrich, St. Louis, MO\], 1× Complete Protease Inhibitor Cocktail, 28 mM β-mercaptoethanol, 120 U/ml RNasin Ribonuclease Inhibitor, Zymolase \[10 kU/ml\]) for 20 min at 30°C. The spheroplasts were centrifuged for 4 min at 1300 × *g* at 4°C and washed twice in 0.1 M potassium phosphate buffer, pH 7.4, with 1.2 M sorbitol. Spheroplasts were then resuspended in 70% ethanol and incubated overnight at 4°C. Afterward, cells were centrifuged at 1300 × *g* at 4°C for 4 min, washed with WASH buffer (0.3 M sodium chloride, 30 mM sodium citrate, and 10% formamide), and incubated in the hybridization solution, containing 0.3 M sodium chloride, 30 mM sodium citrate, 10% dextran sulfate, 10% formamide, 2 mM ribonucleoside vanadyl complexes, and the TAMRA-labeled Stellaris probe mix for *SUC2* (Biosearch Technologies, Novato, CA) overnight at 30°C in a dark chamber. After hybridization, labeled spheroplasts were centrifuged at 1300 × *g*, the hybridization solution aspirated, and the spheroplasts incubated for 30 min at 30°C in WASH buffer. Next cells were centrifuged and resuspended in a solution containing 0.3 M sodium chloride and 30 mM sodium citrate. *SUC2* mRNA colocalization with the ER was visualized using a DeltaVision imaging system (Applied Precision, Issaquah, WA). Images were processed by deconvolution. The localization of a total of 481 granules was scored in 58 WT cells using smFISH in [Figure 3A](#F3){ref-type="fig"}.

Invertase assay
---------------

Invertase secretion was measured as described previously ([@B52]).

Cell preparation for the invertase assay was performed as described in [@B38]). Secreted and nonsecreted activities were expressed in units based on absorption at 540 nm (1 U = 1 μmol glucose released/min per 100 mg dry cells).

Movies
------

Cells endogenously expressing MS2 aptamer--tagged mRNAs were transformed with plasmids expressing MS2-CP-GFP(x3 or x4) to label the mRNA and Sec63-RFP to label ER. Cells were grown to mid log phase at 26°C on liquid synthetic medium and then shifted to medium lacking methionine for 1 h. For *SUC2* mRNA, the cells were grown on low glucose (0.1%)--containing medium to induce *SUC2* expression. Cells were placed on a thin agar block containing synthetic medium lacking methionine and visualized for up to 0.5 h using a DeltaVision imaging system. Images were processed by deconvolution.

Cycloheximide treatment
-----------------------

MS2 aptamer--integrated *SUC2* or *USE1* cells were grown to mid log phase at 26°C in selective medium and then shifted to medium lacking methionine for 1 h. Cycloheximide was then added to a final concentration of 100 μg/ml and incubated for the indicated times (10 or 30 min) at 26°C. The cells were immediately fixed, as described in [@B21]), before RNA visualization.

\[^35^S\]Methionine protein labeling
------------------------------------

WT yeast were grown to mid log phase at 26°C on medium lacking methionine. Aliquots of cells (3.75 OD~600~ units) were treated with CHX (final concentration, 100 μg/ml) for 5 or 15 min and then pulse labeled with \[^35^S\]methionine (125 μCi/ml; PerkinElmer-Cetus, Waltham, MA) for 15 min to label newly synthesized proteins. In parallel, control cells that were not treated with CHX were pulse labeled with \[^35^S\]methionine for 15 min. Cells were collected and washed in a buffer solution containing 50 mM Tris (pH 7.6) and 150 mM NaCl. Cells were lysed as described in [@B28] and separated by SDS--PAGE on 10% polyacrylamide gels.

Immunoprecipitation of protein and RNA
--------------------------------------

Immunoprecipitation (IP) of Myc-She2 was done as described in [@B18]. Briefly, WT yeast (BY4743Hα) expressing either Myc-tagged She2 or the Myc tag empty vector were grown on 200 ml of synthetic selective medium to OD~600~ of 1, after which they were grown for an additional 2 h in selective medium containing 0.1% glucose to induce *SUC2* expression. Cells were centrifuged at 3000 × *g* for 5 min at 4°C and resuspended in 1 ml of lysis buffer (20 mM Tris-Cl, pH 7.5, 150 mM KCl, 5 mM MgCl~2~, 100 U/ml RNasin, 0.1% NP-40, 1 mM dithiothreitol, 2 μg/ml aprotinin, 1 μg/ml pepstatin, 0.5 μg/ml leupeptin, and 0.01 μg/ml benzamidine). Cells (200 OD~600~ units) were broken by vortexing with glass beads (0.5 mm) for 1 h at 4°C and centrifuged at 4000 × *g* for 10 min at 4°C to yield the TCL. For IP and Western analysis, 1 mg of TCL was diluted in lysis buffer (final volume, 1 ml) and subjected to IP with 2 μl of monoclonal anti-Myc antibody (9E10; Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C with rotation. Then 20 μl of a protein G agarose slurry (Santa Cruz Biotechnology) was added and the samples incubated for an additional 1 h at 4°C with rotation. The precipitates were washed (×3) with lysis buffer, electrophoresed on 14% SDS--PAGE gels, and detected in immunoblots with the anti-Myc antibodies. In parallel, 50-μg samples of the TCL were also electrophoresed and detected in blots with anti-Suc2 antibodies (gift from C. Barlowe, Dartmouth University, Hanover, NH), anti-actin antibodies (MP Biomedicals, Solon, OH), and the anti-Myc antibodies. For IP and RNA detection analysis, 3 mg of TCL was diluted in lysis buffer (final volume, 1 ml) and incubated with 10 μl of anti-Myc antibody overnight at 4°C with rotation. Then 30 μl of a protein G agarose slurry (Santa Cruz Biotechnology) was added and the samples incubated for an additional 1 h at 4°C. The agarose beads were washed (×3) with lysis buffer, and protein--RNA complexes were eluted by incubation in 300 μl of elution buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM EDTA, 0.1% SDS), in diethyl pyrocarbonate--treated water with 100 μg/ml proteinase K (Promega) at 65°C for 30 min.

RNA extraction from immunoprecipitated protein--RNA complexes and RT-PCR
------------------------------------------------------------------------

RNA was isolated from the IP eluate by adding 175 μl of MPC Protein Precipitation Reagent (MasterPure RNA Isolation Kit; Epicentre Biotechnologies) per 300 μl volume, as described by the manufacturer, followed by centrifugation at 10,000 × *g* for 10 min at 4°C. The supernatant was transferred into a fresh microcentrifuge tube, and NaOAc (pH 5.4; 0.3 M final concentration) and glycogen (8 μg/ml final concentration; Fermentas/Thermo Scientific, Waltham, MA) were added, followed by thorough mixing. An equal volume of EtOH was then added to the tube, followed by vortexing and incubation of 20 min at −70°C. After centrifugation at 10,000 × *g* for 10 min at 4°C, the RNA pellet was rinsed once with 70% ethanol, air dried, and dissolved in 25 μl of Ultra Pure Water (Biological Industries, Kibbutz Beit-Haemek, Israel). The recovered RNA was subjected to treatment with RQ1 RNase-free DNase (Promega), as detailed by the manufacturer, and 15 μl from this reaction was taken for RT using M-MLV Reverse Transcriptase RNase, H Minus, Point Mutant (Promega), and a random hexamer mixture (Fermentas, Burlington, Canada) in a final volume of 25 μl. For the detection of specific transcripts, 3 μl of reverse-transcribed RNA was amplified by PCR (28 cycles, 20-μl total reaction volume) using Taq Purple Mix (Lambda Biotech, St. Louis, MO) and oligonucleotide primer pairs specific for *ASH1* or *SUC2*. Control reactions (PCR amplification of genomic DNA, PCR mix without template, and PCR amplification of pulled-down RNA without RT) were performed in parallel. PCR products were electrophoresed on 1% agarose gels and photodocumented.

Supplementary Material
======================

###### Supplemental Materials

This article was published online ahead of print in MBoC in Press (<http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-01-0038>) on July 31, 2013.

\*These authors contributed equally.

We thank Yoav Arava, Charles Barlowe, Noga Gadir, Kerry Bloom, Zvulun Elazar, Susan Michaelis, Maya Schuldiner, and Robert Singer for reagents. This study was supported by grants to J.E.G. from the Minerva Foundation, Germany, and the Y. Leon Benoziyo Institute for Molecular Medicine and the Center for Scientific Excellence, Weizmann Institute, Israel. J.E.G. holds the Besen-Brender Chair in Microbiology and Parasitology, Weizmann Institute. E.B. is supported by an Israel Science Foundation First Award and holds the Jerome A., Freda, and Edward M. Siegel Chair, Weizmann Institute.

cER

:   cortical endoplasmic reticulum

CHX

:   cycloheximide

ER

:   endoplasmic reticulum

INT

:   integrated

GFP

:   green fluorescent protein

mPOL

:   mRNA encoding polarity and secretion factor

MS2-CP

:   MS2 bacteriophage coat protein

MS2L

:   MS2 aptamer loop

mSMP

:   mRNA encoding secreted or membrane proteins

m-TAG

:   MS2 aptamer genome-tagging procedure

nER

:   nuclear ER (ER peripheral to the nucleus)

ORF

:   open reading frame

RBP

:   RNA-binding protein

RFP

:   red fluorescent protein

RT-PCT

:   reverse transcription-PCR

smFISH

:   single-molecule fluorescence in situ hybridization

SNARE

:   soluble *N*-ethylmaleimide--sensitive factor attachment protein receptors

SRP

:   signal recognition particle

SSCR

:   signal-sequence coding region

TAMRA

:   tetramethylrhodamine

TMD

:   transmembrane domain

UTR

:   untranslated region

YPD

:   yeast extract--bactopeptone--dextrose
